Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives

H.R. Gosker*, E.F.M. Wouters, G.J. van der Vusse, A.M.W.J. Schols

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

52 Downloads (Pure)


Low exercise tolerance has a large influence on health status in chronic obstructive pulmonary disease and chronic heart failure. In addition to primary organ dysfunction, impaired skeletal muscle performance is a strong predictor of low exercise capacity. There are striking similarities between both disorders with respect to the muscular alterations underlying the impairment. However, different alterations occur in different muscle types. Histologic and metabolic data show that peripheral muscles undergo a shift from oxidative to glycolytic energy metabolism, whereas the opposite is observed in the diaphragm. These findings are in line with the notion that peripheral and diaphragm muscle are limited mainly by endurance and strength capacity, respectively. In both diseases, muscular impairment is multifactorially determined; hypoxia, oxidative stress, disuse, medication, nutritional depletion, and systemic inflammation may contribute to the observed muscle abnormalities and each factor has its own potential for innovative treatment approaches.
Original languageEnglish
Pages (from-to)1033-1047
Number of pages15
JournalAmerican Journal of Clinical Nutrition
Issue number5
Publication statusPublished - 1 Jan 2000

Cite this